A New Framework for Assessing and Managing Malignant Hyperthermia Risk

Join The RYR-1 Foundation for Understanding MH Risk: New Recommendations for Genetic Testing and Clinical Care, a special webinar exploring the recently published article, A Proposed North American Approach for Genetic Testing of Individuals at Risk for Malignant Hyperthermia. Moderated by Dr. Mike Goldberg, Board President & Co-Chair of Research of The RYR-1 Foundation, this webinar will feature Dr. Sheila Riazi, member of The RYR-1 Foundation Scientific Advisory Board and co-author of the publication. Dr. Riazi will discuss a new framework designed to help healthcare providers more effectively assess and manage Malignant Hyperthermia (MH) risk.